Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Company | Date | Price Target | Rating | Analyst |
|---|---|---|---|---|
| 4/13/2026 | $3.83 | Buy → Neutral | Goldman | |
| 3/12/2026 | $5.00 | Hold → Buy | Jefferies | |
| 2/19/2026 | $28.00 | Mkt Perform → Outperform | Raymond James | |
| 9/25/2025 | $48.00 | Neutral → Buy | MoffettNathanson | |
| 9/11/2025 | $47.00 | Neutral → Buy | Seaport Research Partners | |
| 9/11/2025 | $45.00 | Hold → Buy | Deutsche Bank | |
| 9/8/2025 | $50.00 | Neutral → Outperform | Mizuho | |
| 7/10/2025 | Mkt Outperform | Citizens JMP |
For Immediate Release: December 14, 2023 Today, the U.S. Food and Drug Administration is announcing the issuance of nine warning letters to manufacturers and distributors of unapproved and misbranded antimicrobial animal drugs for violations of federal law. The agency is concerned because these products contain antimicrobials that are important in human medicine and using them without medical oversight contribut
Goldman downgraded Petco Health and Wellness from Buy to Neutral and set a new price target of $3.83
Jefferies upgraded Petco Health and Wellness from Hold to Buy and set a new price target of $5.00
Raymond James upgraded Chewy from Mkt Perform to Outperform and set a new price target of $28.00
Chewy, Inc. (NYSE:CHWY) ("Chewy"), today announced it has entered into a definitive agreement to acquire Modern Animal, Inc. ("Modern Animal"), a technology-forward veterinary platform with 29 owned clinics, 24/7 virtual care, and a high-retention membership model. This acquisition represents an important strategic step in Chewy's evolution into a fully integrated pet healthcare ecosystem, combining care, commerce and services across the pet lifecycle. Modern Animal adds a scaled, tech-enabled in-person care model that accelerates Chewy's clinic expansion and complements its existing health, pharmacy and Chewy Vet Care ("CVC") capabilities. The acquisition is expected to add over $125 mil
Chewy, Inc. (NYSE:CHWY) ("Chewy"), a trusted destination for pet parents and partners everywhere, has released its financial results for the fiscal fourth quarter and full year 2025 ended February 1, 2026. Fiscal quarter and year ended February 1, 2026 had 13 and 52 weeks, respectively. Fiscal quarter and year ended February 2, 2025 had 14 and 53 weeks, respectively. Year over year results for Fiscal Q4 2025 and Fiscal Year 2025 below compares US GAAP basis results, unless otherwise normalized for 13-weeks or 52-weeks pro-rata. Fiscal 2025 Results: Net sales of $12.60 billion improved 6.2 percent year over year or 8.3 percent on a normalized 52-week basis Gross margin of 29.8 perc
BEIJING, March 18, 2026 /PRNewswire/ -- TDH Holdings, Inc. (NASDAQ:PETZ) ("TDH" or the "Company"), a PRC-based company that is an owner, operator and manager of commercial real estate properties, announced that it has received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that it is not in compliance with Nasdaq's independent director and audit committee requirements as set forth in Listing Rule 5605. This press release is issued pursuant to Nasdaq Listing Rule 5810(b), which requires disclosure of receipt of a deficiency notification. The notification has no immediate effect on the listing of the Company's common shares,
6-K - TDH Holdings, Inc. (0001684425) (Filer)
6-K - TDH Holdings, Inc. (0001684425) (Filer)
8-K - Chewy, Inc. (0001766502) (Filer)
4 - Petco Health & Wellness Company, Inc. (0001826470) (Issuer)
4 - Petco Health & Wellness Company, Inc. (0001826470) (Issuer)
4 - Petco Health & Wellness Company, Inc. (0001826470) (Issuer)
4 - PETMED EXPRESS INC (0001040130) (Issuer)
4 - PETMED EXPRESS INC (0001040130) (Issuer)
4 - PETMED EXPRESS INC (0001040130) (Issuer)
Chewy, Inc. (NYSE:CHWY) ("Chewy"), a trusted destination for pet parents and partners everywhere, has released its financial results for the fiscal fourth quarter and full year 2025 ended February 1, 2026. Fiscal quarter and year ended February 1, 2026 had 13 and 52 weeks, respectively. Fiscal quarter and year ended February 2, 2025 had 14 and 53 weeks, respectively. Year over year results for Fiscal Q4 2025 and Fiscal Year 2025 below compares US GAAP basis results, unless otherwise normalized for 13-weeks or 52-weeks pro-rata. Fiscal 2025 Results: Net sales of $12.60 billion improved 6.2 percent year over year or 8.3 percent on a normalized 52-week basis Gross margin of 29.8 perc
Delivers Profitability Ahead of Outlook, Reduces Leverage Ratio Provides Fiscal 2026 Outlook*SAN DIEGO, March 11, 2026 /PRNewswire/ -- Petco (NASDAQ:WOOF), the retailer "where the pets go" to find everything they need to live their best lives, today reported its fourth quarter and full year 2025 financial results. https://ir.petco.com/ (PRNewsfoto/Petco Health and Wellness Company, Inc.)" alt="Petco Health + Wellness Company, Inc. Logo https://ir.petco.com/ (PRNewsfoto/Petco Health and Wellness Company, Inc.)"> "In fiscal 2025, we strengthened our leadership team and rebuilt th
Chewy, Inc. (NYSE:CHWY) ("Chewy"), a trusted destination for pet parents and partners everywhere, announced today that it will report fiscal fourth quarter and full year 2025 financial results before the market opens on Wednesday, March 25, 2026. Management will host a conference call and webcast to discuss the company's financial results at 8:00 am ET. To access the conference call by phone, please visit this link for registration (Phone Registration Link) to be provided with dial in details, including a unique PIN to access the conference call. To avoid delays, we encourage participants to register in advance or at a minimum 15 minutes before the start of the call. A live audio webcas
Chewy, Inc. (NYSE:CHWY) ("Chewy"), a leading and trusted destination for pet parents and partners everywhere, announced today the appointment of Chris Deppe as Chief Financial Officer (CFO). Deppe is a seasoned finance and operations leader with more than 20 years of experience. He joined Chewy in 2022 as the Vice President of Supply Chain and Operations Finance, and most recently served as the Head of all Corporate and Commercial Finance Functions. During his tenure, he has played a key role in advancing the company's financial strategy, enhancing operational rigor, and supporting strong business performance aligned with Chewy's long-term strategic priorities. Prior to joining Chewy, D
SAN DIEGO, Feb. 2, 2026 /PRNewswire/ -- Petco (NASDAQ:WOOF), the retailer "where the pets go" to find everything they need to live their best lives, today announced the successful closing of the previously announced long-term debt refinancing and the transition of Glenn Murphy, Executive Chairman of Petco, to Chairman of the Board of Directors, effective February 1. https://ir.petco.com/ (PRNewsfoto/Petco Health and Wellness Company, Inc.)" alt="Petco Health + Wellness Company, Inc. Logo https://ir.petco.com/ (PRNewsfoto/Petco Health and Wellness Company, Inc.)"> Joel Anderso
Seasoned corporate director brings extensive expertise in audit, accounting, and internal controls Fourth independent director to join the board since 2024 DELRAY BEACH, Fla., Oct. 20, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., d/b/a PetMeds and parent company of PetCareRx, (NASDAQ:PETS) (the "Company"), today announced the appointment, effective immediately, of James LaCamp to the Company's Board of Directors (the "Board"), and effective October 30, Mr. LaCamp will become Chair of the Audit Committee of the Board. Mr. LaCamp also qualifies as an "audit committee financial expert" within the meaning of the SEC's rules and regulations. Mr. LaCamp brings close to two decades of experie
SC 13G - PETMED EXPRESS INC (0001040130) (Subject)
SC 13G/A - Chewy, Inc. (0001766502) (Subject)
SC 13G/A - Chewy, Inc. (0001766502) (Subject)